Last updated on November 2017

ROF-MD-07


Brief description of study

ROF-MD-07

Detailed Study Description

A 52 week double-blind, placedbo controlled study to evaluate the effect of roflumilast on the exacerbation rate in patients with COPD.

Clinical Study Identifier: TX81215

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Baylor Scott & White Research ...

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »